logo
Select company
Select metric
$ -2.68EBITDA per Share
VS
Market
9
Sector
24
Industry
32
History
33
$ 9.84Close
$ 8.24 - $ 28.14 52-Week Range
Ticker Information

Ticker

NRIX

Company Name

NURIX THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

NURIX THERAPEUTICS INC - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NRIX - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
9/30/2025$ -225.49M$ -2.68184.16M
6/30/2025$ -188.8M$ -2.25183.88M
3/31/2025$ -191.55M$ -2.29183.56M
12/31/2024$ -176.87M$ -2.64167.12M
9/30/2024$ -160.83M$ -2.21172.78M
6/30/2024$ -149.7M$ -2.4162.38M
3/31/2024$ -130.28M$ -2.37154.9M
12/31/2023$ -130.29M$ -2.4154.34M
9/30/2023$ -135.78M$ -2.5154.39M
6/30/2023$ -145M$ -2.67154.26M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NURIX THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -3.93.
  • Over the past 5 years, NURIX THERAPEUTICS INC's average EBITDAPS has been $ -2.68.
  • The median EBITDAPS for NURIX THERAPEUTICS INC during this period was $ -2.59
  • NURIX THERAPEUTICS INC reached its highest EBITDAPS over the past 5 years at $ -1.97.
  • The lowest EBITDAPS recorded by NURIX THERAPEUTICS INC in the same timeframe $ -3.93

NURIX THERAPEUTICS INC's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
SNDX : SYNDAX PHARMACEUTICALS INC $ -3.63URGN : UROGEN PHARMA LTD $ -2.81TBPH : THERAVANCE BIOPHARMA INC $ 0.96KURA : KURA ONCOLOGY INC $ -2.2GYRE : GYRE THERAPEUTICS INC $ 0.11ZVRA : ZEVRA THERAPEUTICS INC $ 0.67CRMD : CORMEDIX INC $ 0.77NAGE : NIAGEN BIOSCIENCE INC $ 0.25SAGE : SAGE THERAPEUTICS INC $ -4.8EYPT : EYEPOINT PHARMACEUTICALS INC $ -2.48

Similar metrics to Shares WA:

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for NURIX THERAPEUTICS INC is calculated as follows: EBITDA [ $ -61.6M ] / (Shares WA [ 15.67M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -3.93 ]

NRIX - EBITDA per Share, Last 5 years

$ -3.93

Minimum

Dec 31, 2020

$ -1.97

Maximum

Jun 30, 2021

$ -2.68

Average

$ -2.59

Median

EBITDAPS Benchmark Analysis

 The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.01 with a standard deviation of $ 4.26.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -10.86
max$ 13.95
average$ 2.01
median$ 0.99
std$ 4.26